Article

Trypanosoma cruzi Arequipa: a tool for Chagas disease drug discovery

2022-05-10

Abstract excerpt

Trypanosoma cruzi , the causative agent of Chagas disease, is a genuine parasite with a tremendous genetic diversity and a complex life cycle. Scientists have studied this disease for more than 100 years, and Chagas disease drug discovery has been a mainstay due to the absence of an effective treatment. Technical advances in several areas have contributed to a better understanding of the complex biology and life c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a08515d5-a8b9-5a1c-8c88-aeb20065c224
DOI: 10.22541/au.165221106.64228280/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Trypanosoma cruzi Arequipa: a tool for Chagas disease drug discoveryDOI 10.22541/au.165221106.64228280/v1Read

Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models.Semantic proximity Read

Trypanosoma cruzi DTU diversity, benznidazole response, and clinical manifestations of Chagas disease: a seventeen-year systematic review and meta-analysis.Semantic proximity Read

Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversitySemantic proximity Read

DRUG DISCOVERY AND DEVELOPMENT FOR NEGLECTED TROPICAL DISEASESSemantic proximity Read

TcI, TcII and TcVI Trypanosoma cruzi samples from Chagas disease patients with distinct clinical forms and critical analysis of in vitro and in vivo behavior, response to treatment and infection evolution in murine modelSemantic proximity Read

New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infectionsSemantic proximity Read

Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes.Semantic proximity Read

Molecular and biological characterization of Trypanosoma cruzi strains isolated from children from Jequitinhonha Valley, State of Minas Gerais, Brazil.Semantic proximity Read

Broadening the spectrum of ivermectin: Its effect on Trypanosoma cruzi and related trypanosomatidsSemantic proximity Read

Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates.Semantic proximity Read

Metacyclogenesis as the Starting Point of Chagas DiseaseSemantic proximity Read

Fifteen Years after the Definition of <em>Trypanosoma cruzi </em>DTUs: What Have We Learned?Semantic proximity Read